Previous Article | Next Article 
Journal of Clinical Microbiology, April 2000, p. 1461-1467, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of Diagnostic Value and Epidemiological Implications
of PCR for Pneumocystis carinii in Different
Immunosuppressed and Immunocompetent Patient Groups
Andreas
Sing,1,*
Karlheinz
Trebesius,1
Andreas
Roggenkamp,1
Holger
Rüssmann,1
Karin
Tybus,1
Friederike
Pfaff,1
Johannes R.
Bogner,2
Christoph
Emminger,3 and
Jürgen
Heesemann1
Max von Pettenkofer-Institut für
Hygiene und Medizinische Mikrobiologie,1 and
Medizinische Poliklinik, Ludwig
Maximilians-Universität München,2
80336 Munich, and Krankenhaus München Schwabing,
80804 Munich,3 Germany
Received 14 October 1999/Returned for modification 29 November
1999/Accepted 29 January 2000
 |
ABSTRACT |
To evaluate the value of single and nested PCRs for diagnosis of
Pneumocystis carinii pneumonia (PCP) in a variety of
respiratorily distressed patient groups, 574 respiratory samples from
334 patients (89 human immunodeficiency virus [HIV]-positive
patients, 61 transplant recipients, 66 malignancy patients, 34 otherwise immunosuppressed patients, and 84 immunocompetent patients)
were prospectively examined by microscopy and single and nested PCRs.
The resulting data were correlated with clinical evidence of PCP.
Microscopy and single PCR of bronchoalveolar lavage (BAL) specimens
from HIV patients were 100% sensitive and specific in detecting PCP, whereas nested PCR, although being 100% sensitive, reached a
specificity of only 97.5%. In the three non-HIV immunosuppressed
patient groups, both single and nested PCR invariably produced
lower positive predictive values than microscopy. Among
immunocompetent patients, the positive predictive values of both PCRs
were 0%. Therefore, the diagnostic values of the PCR methods tested do
not seem to offer any additional advantage compared to
that of conventional microscopy for these patient groups. However,
nested PCR identified a significant percentage of clinically silent
P. carinii colonizations in about 17 to 20% of
immunocompetent and immunosuppressed non-HIV patients.
 |
INTRODUCTION |
Pneumocystis carinii is
an opportunistic eukaryotic pathogen causing life-threatening
pneumonia (P. carinii pneumonia [PCP]) in
immunosuppressed patients. Since its discovery in the early 1900s, it
was thought to be a protozoon. Then in the 1980s, DNA analysis showed
that this organism is, in fact, a fungal species (for a review, see
reference 25). PCP is still the most common initial AIDS manifestation but has also been described for
immunocompromised patients, i.e., malignancy patients, transplant
recipients, and patients receiving immunosuppressive therapy.
As P. carinii cannot be grown in culture from clinical
specimens, laboratory diagnosis of PCP has relied mainly upon
microscopic demonstration with conventional cytochemical staining,
i.e., with toluidine blue O, Grocott's methenamine silver,
calcofluor for detection of the historically termed cyst stage, and
Giemsa and Wright stains for identification of the traditionally termed
trophozoites. Immunocytochemical staining procedures with monoclonal or
polyclonal antibodies have been developed to increase sensitivity and
specificity (2, 4, 10, 19, 20). All these methods, however,
depend to a high degree on the quality of the specimens obtained for diagnosis. Therefore, invasively obtained respiratory samples such as
bronchoalveolar lavage (BAL) specimens are still the material of choice
for the diagnosis of PCP.
PCR technology was first applied to the diagnosis of PCP by Wakefield
et al. to improve sensitivity and specificity (39). This
promising technology allows PCP diagnosis from less or not invasively
obtained clinical specimens such as induced sputa or oral washings
(14, 16, 17). A nested-PCR approach (42) offers
an even more sensitive and specific tool than the widely used
single-PCR method (39) for detecting P. carinii
DNA. However, the role of PCR in the laboratory diagnosis of PCP has
yet to be defined, especially with regard to patient groups presenting with different grades or causes of immunosuppression. Furthermore, the
diagnostic value of PCR has yet to be evaluated for differing types of
clinical specimens.
Besides these more technical aspects influencing PCP diagnosis, the not
yet completely understood biology of this ubiquitous pathogen and its
still unclear pathology create difficulties in interpreting a positive
PCR result. The issues of whether P. carinii giving rise to
a specific serological antibody response early in childhood
(31) persists for life and whether PCP might result from
reactivation of a persistent infection have not yet been resolved.
Therefore, respiratory samples from latently infected or colonized
persons might yield positive PCR results for P. carinii DNA
not causing overt PCP.
To evaluate the usefulness of PCR for PCP diagnosis, we studied four
patient groups with different degrees or causes of immunosuppression as
well as immunocompetent patients presenting with acute respiratory symptoms.
 |
MATERIALS AND METHODS |
Clinical specimens.
Six hundred twenty-six respiratory
specimens, including 461 BAL specimens, 68 endotracheal aspirates
(ETA), 78 expectorated or induced sputa, and 19 other specimens, were
prospectively obtained from 375 patients (126 females and 249 males;
mean age, 45.7 years; range, 2 months to 90 years) from 1 January 1997 to 31 December 1997. Three hundred thirty-four patients with 574 clinical samples (Table 1) could be
divided into five groups: 89 HIV-positive patients; 61 transplant
recipients (21 bone marrow, 16 lung, 14 heart, 5 heart and lung, and 5 kidney transplant patients); 66 patients with malignancies, including
leukemia, lymphoma, and solid tumors; 34 immunosuppressed patients
(either suffering from some kind of immunodeficiency or receiving
cytotoxic or immunosuppressing medication); and 84 immunocompetent
patients. Immunocompetence was defined by normal immunological
function, no immunosuppressive or cytotoxic therapy, no HIV
seropositivity, no systemic disease, and no malignancy. All
patients were investigated for pulmonary symptoms characterized by
dyspnea, cough, and fever and possibly accompanied by abnormal chest
radiographs. Exact clinical data were obtained by medical chart review
in cases in which conventional staining and/or PCR yielded
positive results. These clinical data included the final
diagnosis of the underlying primary pulmonary disease, microbiological
and (cyto)pathological results of the respiratory specimen under
evaluation and of subsequently obtained material, CD4+
lymphocyte count (if performed), serum lactate dehydrogenase level,
results of antibiotic treatment, prior or subsequent PCP episodes, use
of antipneumocystic prophylaxis, and clinical outcome. Patients with a
negative staining result but positive PCR were thought of as true-PCP
patients if clinical findings were consistent with PCP, no other
microbial pathogen was isolated from respiratory samples, serum lactate
dehydrogenase levels were elevated, and empiric antimicrobial therapy
included an antipneumocystic agent that led to resolution of the
respiratory symptoms. If one or two of the last three criteria were not
met, the patient was considered a possible-PCP patient, and statistical
values were calculated separately for both PCP and non-PCP scenarios.
Only positive microscopical findings were reported to the clinicians.
Therefore, diagnosis and therapy were not based on positive
PCR results
without microscopical
corroboration.
Specimen processing.
Clinical specimens were centrifuged at
3,430 × g for 10 min. A portion of the pellet was
smeared on slides and Giemsa and Grocott stained for microscopic
evaluation. Smears were examined by two microscopists experienced in
P. carinii diagnosis.
DNA extraction and PCR procedures.
Another part of the
pellet was stored at
20°C until required for PCR analysis.
Following overnight proteinase K digestion at 55°C, DNA was extracted
using a Qiagen (Hilden, Germany) tissue kit. A two-step protocol was
applied for nested PCR, as described elsewhere (42);
external primers pAZ 102E and pAZ 102H were first used, which yielded a
340-bp fragment (39), after which a second round of
amplification was performed using the nested primers pLE1
(5'-TCGGACTAGGATATAGCTGG-3') and pLE2
(5'-CCCTTTCGACTATCTACC-3'), which resulted in a 193-bp
product. Primary PCR was performed on 5 µl of proteinase K-treated
samples in 45 µl of PCR reagent mixture containing 20 mM (each) dATP,
dCTP, dGTP, and dTTP (Pharmacia LKB Biotechnology, Freiburg, Germany);
20 pmol of each primer (Metabion, Planegg-Martinsried, Germany); 2.5 U
of Taq polymerase (AmpliTaq; PE Applied Biosystems,
Weiterstadt, Germany); 5 µl of 10× Taq buffer
(Perkin-Elmer [PE] Applied Biosystems); and sterile water. For a hot
start, the PCR reagent mixture was preheated to 85°C for 2 min and
subsequently to 80°C for 5 min before DNA was added. Thirty-five
cycles consisting of denaturation at 94°C for 60 s, annealing at
55°C for 60 s, and extension at 72°C for 90 s were
performed. Thereafter, a final extension for 7 min at 72°C was done.
Two microliters of the primary PCR product was used for the same
hot-start PCR program with 30 cycles. Products of both primary and
nested PCR were investigated by agarose gel electrophoresis, stained
with ethidium bromide, and analyzed under UV light. PCR analysis was
performed without prior knowledge of the conventional-staining
diagnosis. Contamination precautions included use of aerosol barrier
pipette tips and the performance of master mix preparation, DNA
extraction, PCR procedure, and specimen detection in separate rooms.
Several positive (from BAL specimens of PCP patients) and negative
(autoclaved water and the PCR mixture minus the DNA template) controls
were tested simultaneously. For PCR-positive samples with negative
conventional-staining results (PCR-positive samples were reexamined
microscopically by two different persons) DNA isolation was repeated
and an additional PCR was performed. A positive result was accepted
when this PCR determination was also positive.
To show the specificity of the nested PCR for
P. carinii,
DNA sequencing of the amplified gene products of 12 nested-PCR-positive
samples from the four non-HIV groups and from two control specimens
of
two different patients microscopically proven to have PCP was
performed
by the
Taq cycle DyeDeoxy terminator method with an
ABI
PRISM 373A automatic sequencer (PE Applied Biosystems). The
obtained
sequences were compared with known nucleotide sequences
by using the
BLAST program (
1).
 |
RESULTS |
Three hundred thirty-four of 375 patients could clearly be
attributed to one of the five patient groups under study. From these
334 patients with respiratory disease, 574 samples were analyzed (Table
1). For evaluation of the differing diagnostic methods, samples and
patients were analyzed separately for several reasons. First, material
obtained by the same method from different locations during the same
disease episode, e.g., by BAL of various regions of the bronchial tree,
may yield different results. Second, samples obtained at different
points in time during a single episode might differ in their diagnostic
outcome. Third, samples obtained by different means may produce
differing diagnostic results.
Within the HIV-positive group, conventional microscopy of routinely
stained samples and single PCR correctly identified all patients with
clinically proven PCP without producing false-positive results (Table
2). The nested PCR also detected all PCP
patients within the HIV-positive group. One HIV-positive patient who
was found to be P. carinii DNA positive in nested PCR of BAL
material neither had suffered previously from PCP nor developed PCP in a follow-up period of 18 months. In the three non-HIV immunocompromised groups, microscopy detected all clinically proven PCP patients. Relying
on microscopy alone, however, would have caused us to miss four
possible-PCP patients (according to the definition given above) from
within the three patient groups. On the other hand, both single and
nested PCR produced a high number of false-positive results for these
three patient groups. For 14 immunocompetent patients without
clinically proven PCP and negative microscopic results, nested PCR
yielded false-positive results, while for two immunocompetent non-PCP
patients, single PCR yielded positive results.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Results of conventional microscopy and single and nested
PCRs and correlation with clinical evidence for PCP in patients with
acute respiratory symptoms for samples and patients
|
|
A good correlation between the results of microscopy and single and
nested PCRs was found for respiratory samples of HIV-positive patients,
especially when we focused on clinical cases rather than on samples
alone (Table 3). The three sputa positive
by nested PCR only were obtained from a single patient as follow-up to
a PCP episode previously diagnosed from BAL specimens by all three
methods analyzed in this study. Therefore, the patient would have been
missed only by conventional staining or single PCR if no BAL had been
performed. In the other four patient groups, however, microscopy and
PCR results differed markedly, mainly with BAL samples but also with
sputum and ETA specimens. The discrepancies between the three
diagnostic methods performed on differing respiratory materials from
the five different patient groups are presented in Table
4. Discrepancies between conventional
staining and nested PCR were highest among the immunocompromised
groups, with results differing in nearly every sixth case, and were
lowest among the HIV patients. In all five patient groups
almost
independently of the respiratory material investigated
the
discrepancies were largely due to differences between single- and
nested-PCR results, while the results of conventional staining and
single PCR differed less frequently. A detailed list of the statistical
values representing sensitivity, specificity, positive predictive
value, and negative predictive value for the five patient groups and
the investigated patients' respiratory specimens is presented in Table
5. With respiratory disease episodes of
HIV patients being considered, microscopy and single PCR were 100%
sensitive and specific, reaching positive and negative predictive
values of 100%, whereas nested PCR was 100% sensitive and 97.5%
specific, reaching positive and negative predictive values of 97 and
99%. If confirmed- and possible-PCP patients are taken together,
both single and nested PCR did not increase the sensitivity for
samples of any patient group compared to the sensitivity of microscopy,
irrespective of the type of respiratory material examined. However, at
the level of individual samples, the sensitivity with samples of HIV
and malignancy patients could be raised by using both single and nested
PCR compared to that of conventional microscopy alone. In HIV-positive
and transplanted patients, sensitivity rates for BAL specimens were
impressively higher than for sputum and ETA specimens, whereas this
could not be observed in the other three patient groups. Furthermore,
specificities and positive predictive values in all patient groups and
for all differing specimens examined were lower for nested PCR than for conventional microscopy.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Correlation of positive findings by microscopy and PCR
for samples and patients from different patient groups
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Discrepancies between results of conventional staining
and single and nested PCRs for P. carinii from different
patient groups for samples and patients
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Sensitivity, specificity, and positive and negative
predictive values of microscopy and single and nested PCRs for samples
and patients of different patient groups
|
|
 |
DISCUSSION |
To evaluate the usefulness of single and nested PCRs as diagnostic
tools for the diagnosis of PCP and to compare them to conventional microscopy, we analyzed 334 patients presenting with acute respiratory symptoms who could clearly be separated into one of five patient groups
based on different causes of immunosuppression such as HIV,
posttransplantation therapy, malignancies, and other
immunocompromising conditions.
In the HIV patient group, all confirmed-PCP cases were detected by
each of the three diagnostic methods examined
microscopy and single
and nested PCRs
reaching sensitivities of 100%. However, nested PCR
exhibited a higher sensitivity rate with BAL specimens as well as
sputum and ETA samples than those of single PCR or microscopy. On the
other hand, specificities and positive predictive values were higher
for microscopy and single PCR than for nested PCR in this patient
group. Therefore, by relying on microscopy alone, no HIV-positive PCP
patient would have been missed while by nested PCR alone, one patient
out of 89 would have wrongly identified as suffering from PCP.
In the other three immunocompromised patient groups, the
discrepancies between the results obtained by conventional and
molecular methods were even more profound. If only clinically
confirmed cases of PCP had been considered, both PCR methods would have produced a significant percentage of false-positive results while microscopy would have correctly identified all clinically confirmed PCP
cases without yielding a false-positive result. If only confirmed- and
possible-PCP cases had been considered, microscopy would have missed
several PCP episodes; in this scenario, however, both PCRs would have
also yielded a remarkable number of false-positive findings. For nested
PCR, the positive predictive values for the three immunocompromised
patient groups were less than 40%. Furthermore, in all five patient
groups and for almost every respiratory material analyzed, the
discrepancies between the different diagnostic methods were largely due
to the differences between single- and nested-PCR results, while the
results differed less frequently between conventional microscopy and
single PCR. This further underscores the vague value of nested PCR in
the diagnosis of PCP. In addition, it might be wise to consider that
conventional microscopy of a Giemsa-stained BAL specimen obtained from
a bone marrow transplant recipient revealed a diagnosis of
Toxoplasma gondii pneumonia which would have been missed by
performing P. carinii PCR alone.
In most studies comparing microscopy- and PCR-based methods for PCP
diagnosis (2, 4, 6, 7, 8, 10, 12, 13, 15, 18, 19, 21, 22, 24, 26,
27, 28, 29, 32, 33, 34, 35, 36, 37, 38, 40, 41), no significant advantage of nested PCR, with regard to sensitivity and specificity compared to those of morphological diagnosis, could be established when
BAL specimens were examined. For HIV patients, however, the majority of
studies report higher sensitivity rates for single and nested PCR than
for microscopy when induced sputum is the material examined. This
observation was corroborated in our study for nested PCR only, although
no PCP patient was missed by relying on microscopy alone.
Interestingly, in contrast to results from studies of postmortem lung
material (11, 23, 30) or of respiratory samples from
immunocompetent patients with acute respiratory diseases (41,
42), a significant percentage (17%) of immunocompetent non-PCP
patients in our study were identified as P. carinii DNA positive by nested PCR, suggesting colonization within the
immunocompetent patient group. Similar colonization rates have been
found for chronic obstructive pulmonary disease patients
(5), immunocompetent patients with respiratory diseases
(3), and children with chronic respiratory disorders in the
absence of underlying immunodeficiencies (9). Similar
percentages of P. carinii carriage ranging from 17 to 20%
were detected by nested PCR in all three non-HIV immunocompromised groups, despite varying degrees of immunosuppression. In the HIV group,
however, colonization with P. carinii as defined by a
positive nested-PCR result was found only for a single patient in the
absence of clinically manifested PCP (1.1% of HIV patients in our
study population). These findings indicate that P. carinii
colonization can exist in different immunocompetent and -compromised
patient groups without causing overt PCP. The observation that
nested-PCR results correlated very well with the absence or presence of
PCP in HIV patients with acute respiratory symptoms further suggests that P. carinii colonization occurs rarely in association
with HIV infection without leading to PCP. Therefore, it may be
concluded that PCP does not usually result from reactivation of a
latent infection during immunosuppression, since (with one exception) in almost no non-PCP HIV-infected patient could P. carinii
DNA be detected by nested PCR. The immunological status of the HIV patients in our study was of such quality that P. carinii
DNA detection by nested PCR almost invariably correlated with clinical PCP, underscoring the pathogenetic potential of P. carinii
in this patient group.
Taken together, the data of this study indicate that nested PCR, albeit
useful in epidemiological studies, has only limited value in the
diagnosis of overt PCP due to the high number of false-positive results
and low positive-predictive values obtained for non-HIV
immunocompromised and immunocompetent patients. Even with HIV patients,
for whom the differences between the diagnostic results of microscopy
and single and nested PCRs were quite marginal, microscopy and single
PCR performed better than nested PCR with regard to specificity and
positive predictive value, when patients rather than individual
specimens were analyzed. Therefore, the timing of collection, amount,
and quality of respiratory material seems to be more important for
obtaining rapid and significant laboratory results in the diagnosis of
PCP than the replacement of conventional microscopy by molecular methods.
 |
ACKNOWLEDGMENT |
We thank Randy Caldwell for critically reading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Max von
Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie,
Pettenkoferstraße 9a, 80336 Munich, Germany. Phone: 49-89-5160-5293. Fax: 49-89-5160-5223. E-mail:
sing{at}m3401.mpk.med.uni-muenchen.de.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 2.
|
Armbruster, C.,
L. Pokieser, and A. Hassl.
1995.
Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients. Comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction.
Acta Cytol.
39:1089-1093[Medline].
|
| 3.
|
Armbruster, C.,
A. Hassl, and S. Kriwanek.
1997.
Pneumocystis carinii colonization in the absence of immunosuppression.
Scand. J. Infect. Dis.
29:591-593[Medline].
|
| 4.
|
Blumenfeld, W.,
O. McCook,
M. Holodniy, and D. A. Katzenstein.
1992.
Correlation of morphologic diagnosis of Pneumocystis carinii with the presence of pneumocystis DNA amplified by the polymerase chain reaction.
Mod. Pathol.
5:103-106[Medline].
|
| 5.
|
Calderon, E. J.,
C. Regordan,
F. J. Medrano,
M. Ollero, and J. M. Varela.
1996.
Pneumocystis carinii infection in patients with chronic bronchial disease.
Lancet
347:977[Medline].
|
| 6.
|
Caliendo, A. M.,
P. L. Hewitt,
J. M. Allega,
A. Keen,
K. L. Ruoff, and M. J. Ferraro.
1998.
Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens.
J. Clin. Microbiol.
36:979-982[Abstract/Free Full Text].
|
| 7.
|
Cartwright, C. P.,
N. A. Nelson, and V. J. Gill.
1994.
Development and evaluation of a rapid and simple procedure for detection of Pneumocystis carinii by PCR.
J. Clin. Microbiol.
32:1634-1638[Abstract/Free Full Text].
|
| 8.
|
Chouaid, C.,
P. Roux,
I. Lavard,
J. L. Poirot, and B. Housset.
1995.
Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients. A clinical and cost-analysis study.
Am. J. Clin. Pathol.
104:72-75[Medline].
|
| 9.
|
Contini, C.,
M. P. Villa,
R. Romani,
R. Merolla,
S. Delia, and R. Ronchetti.
1998.
Detection of Pneumocystis carinii among children with chronic respiratory disorders in the absence of HIV infection and immunodeficiency.
J. Med. Microbiol.
47:329-333[Abstract/Free Full Text].
|
| 10.
|
Eisen, D.,
B. C. Ross,
J. Fairbairn,
R. J. Warren,
R. W. Baird, and B. Dwyer.
1994.
Comparison of Pneumocystis carinii detection by toluidine blue O staining, direct immunofluorescence and DNA amplification in sputum specimens from HIV positive patients.
Pathology
26:198-200[CrossRef][Medline].
|
| 11.
|
Esterly, J. A.
1968.
Pneumocystis carinii in lungs of adults at autopsy.
Am. Rev. Respir. Dis.
97:935-937[Medline].
|
| 12.
|
Evans, R.,
A. W. Joss,
T. H. Pennington, and D. O. Ho Yen.
1995.
The use of a nested polymerase chain reaction for detecting Pneumocystis carinii from lung and blood in rat and human infection.
J. Med. Microbiol.
42:209-213[Abstract/Free Full Text].
|
| 13.
|
Evans, R.,
A. W. Joss,
D. Parratt,
T. H. Pennington, and D. O. Ho Yen.
1995.
The role of a nested polymerase chain reaction in the diagnosis of Pneumocystis carinii pneumonia.
J. Clin. Pathol. Mol. Pathol.
48:M347-M350.
|
| 14.
|
Evans, R., and D. O. Ho Yen.
1998.
Non-invasive diagnosis of Pneumocystis carinii pneumonia.
Lancet
351:218[Medline].
|
| 15.
|
Galan, F.,
J. L. Oliver,
P. Roux,
J. L. Poirot, and G. Bereziat.
1991.
Detection of Pneumocystis carinii DNA by polymerase chain reaction compared to direct microscopy and immunofluorescence.
J. Protozool.
38:199S-200S[Medline].
|
| 16.
|
Helweg-Larsen, J.,
J. S. Jensen,
T. Benfield,
U. G. Svendsen,
J. D. Lundgren, and B. Lundgren.
1998.
Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples.
J. Clin. Microbiol.
36:2068-2072[Abstract/Free Full Text].
|
| 17.
|
Helweg-Larsen, J.,
J. S. Jensen, and B. Lundgren.
1997.
Non-invasive diagnosis of Pneumocystis carinii pneumonia by PCR on oral washes.
Lancet
350:1363[Medline].
|
| 18.
|
Leibovitz, E.,
H. Pollack,
T. Moore,
J. Papellas,
L. Gallo,
K. Krasinski, and W. Borkowsky.
1995.
Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by human immunodeficiency virus.
J. Clin. Microbiol.
33:3004-3007[Abstract].
|
| 19.
|
Leigh, T. R.,
A. E. Wakefield,
S. E. Peters,
J. M. Hopkin, and J. V. Collins.
1992.
Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy.
Transplantation
54:468-470[Medline].
|
| 20.
|
Leigh, T. R.,
B. G. Gazzard,
A. Rowbottom, and J. V. Collins.
1993.
Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia.
J. Clin. Pathol.
46:140-144[Abstract/Free Full Text].
|
| 21.
|
Lipschik, G. Y.,
V. J. Gill,
J. D. Lundgren,
V. A. Andrawis,
N. A. Nelson,
J. O. Nielsen,
F. P. Ognibene, and J. A. Kovacs.
1992.
Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood.
Lancet
340:203-206[CrossRef][Medline].
|
| 22.
|
Lu, J. J.,
C. H. Chen,
M. S. Bartlett,
J. W. Smith, and C. H. Lee.
1995.
Comparison of six different PCR methods for detection of Pneumocystis carinii.
J. Clin. Microbiol.
33:2785-2788[Abstract].
|
| 23.
|
Millard, P. R., and A. R. Heryet.
1988.
Observations favouring Pneumocystis carinii pneumonia as a primary infection: a monoclonal antibody study on paraffin sections.
J. Pathol.
154:365-370[CrossRef][Medline].
|
| 24.
|
Moonens, F.,
C. Liesnard,
F. Brancart,
J. P. Van Vooren, and E. Serruys.
1995.
Rapid simple and nested polymerase chain reaction for the diagnosis of Pneumocystis carinii pneumonia.
Scand. J. Infect. Dis.
27:358-362[Medline].
|
| 25.
|
Ng, V. L.,
D. M. Yajko, and W. K. Hadley.
1997.
Extrapulmonary pneumocystosis.
Clin. Microbiol. Rev.
10:410-418.
|
| 26.
|
Nogues, A.,
M. Garcia,
C. Rivas,
M. Falguera,
T. Puig, and A. Ruiz.
1993.
Detección de Pneumocystis carinii en muestras clínicas por la reacción en cadena de la polimerasa. Comparación con la técnica de metenamina de plata.
Enferm. Infecc. Microbiol. Clin.
11:143-146[Medline].
|
| 27.
|
Oka, S.,
K. Kitada,
T. Kohjin,
Y. Nakamura,
S. Kimura, and K. Shimada.
1993.
Direct monitoring as well as sensitive diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction on sputum samples.
Mol. Cell. Probes
7:419-424[CrossRef][Medline].
|
| 28.
|
Olsson, M.,
K. Elvin,
S. Lofdahl, and E. Linder.
1993.
Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction.
J. Clin. Microbiol.
31:221-226[Abstract/Free Full Text].
|
| 29.
|
Olsson, M.,
K. Elvin,
C. Lidman,
S. Lofdahl, and E. Linder.
1996.
A rapid and simple nested PCR assay for the detection of Pneumocystis carinii in sputum samples.
Scand. J. Infect. Dis.
28:597-600[Medline].
|
| 30.
|
Peters, S. E.,
A. E. Wakefield,
K. Sinclair,
P. R. Millard, and J. M. Hopkin.
1992.
A search for Pneumocystis carinii in post-mortem lungs by DNA amplification.
J. Pathol.
166:195-198[CrossRef][Medline].
|
| 31.
|
Pifer, L. L.,
W. T. Hughes,
S. Stagno, and D. Woods.
1978.
Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children.
Pediatrics
61:35-41[Abstract/Free Full Text].
|
| 32.
|
Rabodonirina, M.,
D. Raffenot,
L. Cotte,
A. Boibieux,
M. Mayencon,
G. Bayle,
F. Persat,
F. Rabatel,
C. Trepo,
D. Peyramond, and M. A. Piens.
1997.
Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: use of a simple DNA extraction procedure and nested PCR.
J. Clin. Microbiol.
35:2748-2751[Abstract].
|
| 33.
|
Ribes, J. A.,
A. H. Limper,
M. J. Espy, and T. F. Smith.
1997.
PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity.
J. Clin. Microbiol.
35:830-835[Abstract].
|
| 34.
|
Roux, P.,
I. Lavrard,
J. L. Poirot,
C. Chouaid,
M. Denis,
J. L. Olivier,
M. Nigou, and M. Miltgen.
1994.
Usefulness of PCR for detection of Pneumocystis carinii DNA.
J. Clin. Microbiol.
32:2324-2326[Abstract/Free Full Text].
|
| 35.
|
Savoia, D.,
M. Millesimo,
I. Cassetta,
B. Forno, and P. Caramello.
1997.
Detection of Pneumocystis carinii by DNA amplification in human immunodeficiency virus-positive patients.
Diagn. Microbiol. Infect. Dis.
29:61-65[CrossRef][Medline].
|
| 36.
|
Skot, J.,
A. G. Lerche,
H. J. Kolmos,
J. O. Nielsen,
L. R. Mathiesen, and J. D. Lundgren.
1995.
Pneumocystis carinii in bronchoalveolar lavage and induced sputum: detection with a nested polymerase chain reaction.
Scand. J. Infect. Dis.
27:363-367[Medline].
|
| 37.
|
Tamburrini, E.,
P. Mencarini,
A. De Luca,
A. Antinori,
E. Visconti,
A. Ammassari,
L. Ortona,
E. Ortona,
A. Siracusano, and G. Vicari.
1993.
Simple and rapid two-step polymerase chain reaction for diagnosis of Pneumocystis carinii infection.
J. Clin. Microbiol.
31:2788-2789[Abstract/Free Full Text].
|
| 38.
|
Tamburrini, E.,
P. Mencarini,
A. De Luca,
G. Maiuro,
G. Ventura,
A. Antinori,
A. Ammassari,
E. Visconti,
L. Ortona,
A. Siracusano,
E. Ortona, and G. Vicari.
1993.
Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens.
J. Med. Microbiol.
38:449-453[Abstract/Free Full Text].
|
| 39.
|
Wakefield, A. E.,
F. J. Pixley,
S. Banerji,
K. Sinclair,
R. F. Miller,
E. R. Moxon, and J. M. Hopkin.
1990.
Detection of Pneumocystis carinii with DNA amplification.
Lancet
336:451-453[CrossRef][Medline].
|
| 40.
|
Wakefield, A. E.,
L. Guiver,
R. F. Miller, and J. M. Hopkin.
1991.
DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia.
Lancet
337:1378-1379[CrossRef][Medline].
|
| 41.
|
Weig, M.,
H. Klinker,
B. H. Bogner,
A. Meier, and U. Gross.
1997.
Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups.
J. Clin. Microbiol.
35:1445-1449[Abstract].
|
| 42.
|
Weig, M.,
H. Klinker,
M. Wilhelm,
K. Lemmer, and U. Gross.
1996.
Correlation of Pneumocystis carinii PCR with clinical diagnosis in immunocompromised patients.
Lancet
347:1266[Medline].
|
Journal of Clinical Microbiology, April 2000, p. 1461-1467, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Azoulay, E., Bergeron, A., Chevret, S., Bele, N., Schlemmer, B., Menotti, J.
(2009). Polymerase Chain Reaction for Diagnosing Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients With Pulmonary Infiltrates. Chest
135: 655-661
[Abstract]
[Full Text]
-
Schmoldt, S., Schuhegger, R., Wendler, T., Huber, I., Sollner, H., Hogardt, M., Arbogast, H., Heesemann, J., Bader, L., Sing, A.
(2008). Molecular Evidence of Nosocomial Pneumocystis jirovecii Transmission among 16 Patients after Kidney Transplantation. J. Clin. Microbiol.
46: 966-971
[Abstract]
[Full Text]
-
Takeuchi, T, Tatsuki, Y, Nogami, Y, Ishiguro, N, Tanaka, Y, Yamanaka, H, Kamatani, N, Harigai, M, Ryu, J, Inoue, K, Kondo, H, Inokuma, S, Ochi, T, Koike, T
(2008). Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis
67: 189-194
[Abstract]
[Full Text]
-
Freeman, A. F., Davis, J., Anderson, V. L., Barson, W., Darnell, D. N., Puck, J. M., Holland, S. M.
(2006). Pneumocystis jiroveci Infection in Patients With Hyper-Immunoglobulin E Syndrome. Pediatrics
118: e1271-e1275
[Abstract]
[Full Text]
-
Flori, P., Bellete, B., Durand, F., Raberin, H., Cazorla, C., Hafid, J., Lucht, F., Sung, R. T. M.
(2004). Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol
53: 603-607
[Abstract]
[Full Text]
-
Larsen, H. H., Masur, H., Kovacs, J. A., Gill, V. J., Silcott, V. A., Kogulan, P., Maenza, J., Smith, M., Lucey, D. R., Fischer, S. H.
(2002). Development and Evaluation of a Quantitative, Touch-Down, Real-Time PCR Assay for Diagnosing Pneumocystis carinii Pneumonia. J. Clin. Microbiol.
40: 490-494
[Abstract]
[Full Text]
-
Kovacs, J. A., Gill, V. J., Meshnick, S., Masur, H.
(2001). New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia. JAMA
286: 2450-2460
[Abstract]
[Full Text]
-
Sing, A., Geiger, A. M., Hogardt, M., Heesemann, J.
(2001). Pneumocystis carinii Carriage among Cystic Fibrosis Patients, as Detected by Nested PCR. J. Clin. Microbiol.
39: 2717-2718
[Abstract]
[Full Text]